Catabasis Pharmaceuticals Announces Reverse Stock Split

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Catabasis Pharmaceuticals announces it will effect a one-for-ten reverse stock split of its common stock that will be effective on December 28, 2018.

Source link